Cargando…
Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
PURPOSE: To evaluate whether presurgical treatment using long-acting somatostatin receptor ligands (SRL) may change pituitary tumor consistency and improve surgical outcome in GH-secreting pituitary macroadenomas. METHODS: Retrospective study of 40 patients with GH-secreting pituitary macroadenomas...
Autores principales: | Araujo-Castro, Marta, Pian, Héctor, Ruz-Caracuel, Ignacio, Acitores Cancela, Alberto, Pascual-Corrales, Eider, Rodríguez Berrocal, Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923129/ https://www.ncbi.nlm.nih.gov/pubmed/33289697 http://dx.doi.org/10.1530/EC-20-0414 |
Ejemplares similares
-
Radiological Knosp, Revised-Knosp, and Hardy–Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases
por: Araujo-Castro, Marta, et al.
Publicado: (2022) -
Dense calcification in a GH-secreting pituitary macroadenoma
por: Ibrahim, Ramez, et al.
Publicado: (2014) -
A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021) -
Growth Hormone (GH) and Thyroid Stimulating Hormone (TSH) Co-Secreting Pituitary Macroadenoma
por: Maliakal, Alvin, et al.
Publicado: (2021) -
Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma
por: Johnston, Philip C, et al.
Publicado: (2015)